Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
23andMe
About
23andMe is a DNA testing technology company that enables its users to access their ancestry, genealogy, and inherited traits.
- 501 - 1000
Details
- Last Funding Type
- Series F
- Last Funding Money Raised
- $250M
- Industries
- Biotechnology,Genetics,Life Science
- Founded date
- Apr 1, 2006
- Number Of Employee
- 501 - 1000
- Operating Status
- Active
23andMe is a human genome research company enabling users to study their ancestry, genealogy, and inherited traits.A startup co-founded by Linda Avey and Anne Wojcicki, the wife of Google co-founder Sergey Brin, 23andMe has plans to make the human genome searchable. Brin, along with Google, gave 23andMe $3.9 million as part of a series A in May of 2007.The company was named after the number of chromosome pairs in humans. They aim to help people understand what their genes mean by indexing them and highlighting significant findings.23andMe allows its clients/users to study their ancestry, genealogy, and inherited traits. The company also markets to researchers and scientists, for whom they provide neatly categorized and easily searchable data.One reason the Google investment in 23andMe made sense, was that this company could enable the search giant to index another facet of the world's information. With the Biotech and Health Care industries growing rapidly, 23andMe could help Google get and maintain a market hold in these already multi-billion dollar areas.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 29, 2020 | Series F | $82.50M | 2 |
Sequoia Capital
|
— | Detail |
| Sep 5, 2017 | Series F | $250M | 1 |
Sequoia Capital
|
— | Detail |
| Oct 13, 2016 | Grant | $1.70M | 1 |
National Institutes of Health
|
— | Detail |
| Jul 29, 2014 | Grant | $1.40M | 1 |
National Institutes of Health
|
— | Detail |
Investments
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jul 20, 2015
Doctor On Demand
|
Series B | $62.74M | Health Care | — |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Sequoia Capital
|
Yes | Series F |
|
National Institutes of Health
|
Yes | Grant |
ACE & Company
|
— | Series F |
Acquisition
23andMe has acquired 1 organizations. Their most recent acquisition was Lemonaid Health on Oct 22, 2021. They acquired Lemonaid Health for $400M.
|
Date
Company Name
|
Industry | Acquisition Type | Price | |
|---|---|---|---|---|
|
Oct 22, 2021
Lemonaid Health
|
Artificial Intelligence | acquisition | $ 400M | Detail |
